Contact – +1-276-477-5910
 Email – info@supplydemandmarketresearch.com

Home >>

Healthcare

>>

Global Digital Respiratory Solutions Market


Global Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Region: Trend Forecast and Growth Opportunity

Report code: SDMRHE1356173 | Industry: Healthcare | Published On: 44040


Global digital respiratory solutions market will reach $319.3 million by 2030, growing by 36.2% annually over 2020-2030 driven by the rising demand for air filtration amid COVID-19 pandemic.
Highlighted with 84 tables and 76 figures, this 164-page report “Global Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global digital respiratory solutions market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global digital respiratory solutions market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Region.

Based on Product Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Therapeutic Devices
• Inhalers
• Nebulizers
Diagnostic Devices
• Spirometers
• Asthma Monitors
• Other Diagnostic Devices
Sensors and Apps

Based on Indication, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• COVID-19 Caused Diseases
• Other Diseases

Based on Distribution Channel, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Geographically, the following regions together with the listed national/local markets are fully investigated:
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
• North America (U.S., Canada, and Mexico)
• South America (Brazil, Chile, Argentina, Rest of South America)
• RoW (Saudi Arabia, UAE, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Product Type, Indication, and Distribution Channel over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in global digital respiratory solutions market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
3M Health Care Limited
Adherium Limited
Amiko Digital Health Limited
AsthmaMD
AstraZeneca plc
Boehringer Ingelheim International GmbH
Capsule Technologies, Inc.
Cohero Health
GlaxoSmithKline plc
Kaia Health Software GmbH
Medical International Research (MIR)
Novartis AG
NuvoAir
Reciprocal Labs (Propeller Health)
Sensiron AG
Tactio Health
Teva Pharmaceuticals Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1  Introduction  8
1.1  Industry  Definition  and  Research  Scope  8
1.1.1  Industry  Definition  8
1.1.2  Research  Scope  9
1.2  Research  Methodology  12
1.2.1  Overview  of  Market  Research  Methodology  12
1.2.2  Market  Assumption  13
1.2.3  Secondary  Data  13
1.2.4  Primary  Data  13
1.2.5  Data  Filtration  and  Model  Design  15
1.2.6  Market  Size/Share  Estimation  16
1.2.7  Research  Limitations  17
1.3  Executive  Summary  18
2  Market  Overview  and  Dynamics  20
2.1  Market  Size  and  Forecast  20
2.1.1  Impact  of  COVID-19  on  the  Market  21
2.2  Major  Growth  Drivers  23
2.3  Market  Restraints  and  Challenges  28
2.4  Emerging  Opportunities  and  Market  Trends  31
2.5  Porter’s  Fiver  Forces  Analysis  35
3  Segmentation  of  Global  Market  by  Product  Type  40
3.1  Market  Overview  by  Product  Type  40
3.2  Therapeutic  Devices  42
3.2.1  Inhalers  43
3.2.2  Nebulizers  44
3.3  Diagnostic  Devices  45
3.3.1  Spirometers  47
3.3.2  Asthma  Monitors  48
3.3.3  Other  Diagnostic  Devices  49
3.4  Sensors  and  Apps  50
4  Segmentation  of  Global  Market  by  Indication  51
4.1  Market  Overview  by  Indication  51
4.2  Asthma  53
4.3  Chronic  Obstructive  Pulmonary  Disease  (COPD)  54
4.4  COVID-19  Caused  Diseases  55
4.5  Other  Diseases  56
5  Segmentation  of  Global  Market  by  Distribution  Channel  57
5.1  Market  Overview  by  Distribution  Channel  57
5.2  Hospital  Pharmacies  59
5.3  Retail  Pharmacies  60
5.4  Online  Pharmacies  61
6  Segmentation  of  Global  Market  by  Region  62
6.1  Geographic  Market  Overview  2019-2030  62
6.2  North  America  Market  2019-2030  by  Country  68
6.2.1  Overview  of  North  America  Market  68
6.2.2  U.S.  72
6.2.3  Canada  76
6.2.4  Mexico  78
6.3  European  Market  2019-2030  by  Country  80
6.3.1  Overview  of  European  Market  80
6.3.2  Germany  84
6.3.3  UK  86
6.3.4  France  88
6.3.5  Spain  90
6.3.6  Italy  92
6.3.7  Russia  94
6.3.8  Rest  of  European  Market  96
6.4  Asia-Pacific  Market  2019-2030  by  Country  98
6.4.1  Overview  of  Asia-Pacific  Market  98
6.4.2  Japan  102
6.4.3  China  105
6.4.4  Australia  108
6.4.5  India  110
6.4.6  South  Korea  112
6.4.7  Rest  of  APAC  Region  114
6.5  South  America  Market  2019-2030  by  Country  116
6.5.1  Argentina  119
6.5.2  Brazil  121
6.5.3  Chile  123
6.5.4  Rest  of  South  America  Market  125
6.6  MEA  Market  2019-2030  by  Country  126
6.6.1  UAE  129
6.6.2  Saudi  Arabia  131
6.6.3  South  Africa  133
6.6.4  Other  National  Markets  135
7  Competitive  Landscape  136
7.1  Overview  of  Key  Vendors  136
7.2  New  Product  Launch,  Partnership,  Investment,  and  M&A  139
7.3  Company  Profiles  140
3M  Health  Care  Limited  140
Adherium  Limited  142
Amiko  Digital  Health  Limited  143
AsthmaMD  144
AstraZeneca  plc  145
Boehringer  Ingelheim  International  GmbH  146
Capsule  Technologies,  Inc.  147
Cohero  Health  148
GlaxoSmithKline  plc  149
Kaia  Health  Software  GmbH  150
Medical  International  Research  (MIR)  151
Novartis  AG  152
NuvoAir  153
Reciprocal  Labs  (Propeller  Health)  154
Sensiron  AG  155
Tactio  Health  156
Teva  Pharmaceuticals  Industries  Ltd.  157
8  Investing  in  Global  Market:  Risk  Assessment  and  Management  158
8.1  Risk  Evaluation  of  Global  Market  158
8.2  Critical  Success  Factors  (CSFs)  161
Related  Reports  and  Products  164
Table 1. Snapshot of Global Digital Respiratory Solutions Market, 2019-2030 19
Table 2. Main Product Trends and Market Opportunities in Global Digital Respiratory Solutions Market 31
Table 3. Global Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 40
Table 4. Global Digital Respiratory Solutions Market: Therapeutic Devices by Type, 2019-2030, $ mn 42
Table 5. Global Digital Respiratory Solutions Market: Diagnostic Devices by Type, 2019-2030, $ mn 46
Table 6. Global Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 51
Table 7. Global Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 57
Table 8. Global Digital Respiratory Solutions Market by Region, 2019-2030, $ mn 63
Table 9. Total Health Expenditure per capita in PPP International U.S. Dollars by Country 65
Table 10. Leading National Digital Respiratory Solutions Market, 2019 and 2030, $ mn 67
Table 11. North America Digital Respiratory Solutions Market by Country, 2019-2030, $ mn 70
Table 12. U.S. Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 74
Table 13. U.S. Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 74
Table 14. U.S. Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 74
Table 15. Canada Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 77
Table 16. Canada Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 77
Table 17. Canada Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 77
Table 18. Mexico Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 79
Table 19. Mexico Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 79
Table 20. Mexico Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 79
Table 21. Europe Digital Respiratory Solutions Market by Country, 2019-2030, $ mn 83
Table 22. Germany Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 85
Table 23. Germany Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 85
Table 24. Germany Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 85
Table 25. UK Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 87
Table 26. UK Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 87
Table 27. UK Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 87
Table 28. France Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 89
Table 29. France Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 89
Table 30. France Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 89
Table 31. Spain Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 91
Table 32. Spain Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 91
Table 33. Spain Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 91
Table 34. Italy Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 93
Table 35. Italy Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 93
Table 36. Italy Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 93
Table 37. Russia Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 95
Table 38. Russia Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 95
Table 39. Russia Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 95
Table 40. Digital Respiratory Solutions Market in Rest of Europe by Country, 2019-2030, $ mn 97
Table 41. APAC Digital Respiratory Solutions Market by Country, 2019-2030, $ mn 100
Table 42. Japan Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 104
Table 43. Japan Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 104
Table 44. Japan Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 104
Table 45. China Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 107
Table 46. China Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 107
Table 47. China Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 107
Table 48. Australia Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 109
Table 49. Australia Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 109
Table 50. Australia Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 109
Table 51. India Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 111
Table 52. India Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 111
Table 53. India Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 111
Table 54. South Korea Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 113
Table 55. South Korea Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 113
Table 56. South Korea Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 113
Table 57. Digital Respiratory Solutions Market in Rest of APAC by Country, 2019-2030, $ mn 115
Table 58. South America Digital Respiratory Solutions Market by Country, 2019-2030, $ mn 118
Table 59. Argentina Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 120
Table 60. Argentina Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 120
Table 61. Argentina Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 120
Table 62. Brazil Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 122
Table 63. Brazil Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 122
Table 64. Brazil Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 122
Table 65. Chile Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 124
Table 66. Chile Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 124
Table 67. Chile Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 124
Table 68. MEA Digital Respiratory Solutions Market by Country, 2019-2030, $ mn 128
Table 69. UAE Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 130
Table 70. UAE Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 130
Table 71. UAE Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 130
Table 72. Saudi Arabia Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 132
Table 73. Saudi Arabia Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 132
Table 74. Saudi Arabia Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 132
Table 75. South Africa Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 134
Table 76. South Africa Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 134
Table 77. South Africa Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 134
Table 78. 3M Health Care Limited: Company Snapshot 140
Table 79. 3M Health Care Limited: Business Segmentation 140
Table 80. 3M Health Care Limited: Product Portfolio 141
Table 81. 3M Health Care Limited: Revenue, 2016-2018, $ mn 141
Table 82. 3M Health Care Limited: Recent Developments 141
Table 83. Risk Evaluation for Investing in Global Market, 2019-2030 159
Table 84. Critical Success Factors and Key Takeaways 162
 Feel free to contact us

 
Choose License Type
Select User Type


Report code




x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT